Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors May 5, 2021
Protenus’ 5th Annual PANDAS Conference Cultivates Innovation and Compliance Best Practices Throughout COVID-19 Pandemic May 5, 2021
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma May 4, 2021
Centivo launches new health plan for self-funded employers in Iowa utilizing Incirca Health Network, powered by MercyOne May 4, 2021
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease May 1, 2021